Skip to main content
Fig. 10 | BMC Cancer

Fig. 10

From: Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma

Fig. 10

MIA PaCa-2 and Patu8988, which were treated with Phenformin and Pyrimethamine respectively, displayed slow proliferation. IC50 was evaluated by CCK8 in HPDE, MIA PaCa-2 and Patu8988 cells treated with Phenformin (A) and Pyrimethamine (B) Cell proliferation was measured by CCK8 assay in MIA PaCa-2 treated with Phenformin (C) and Patu8988 treated with Pyrimethamine (D) at different doses for 4 days

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us